A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.
Identifieur interne : 000186 ( PubMed/Checkpoint ); précédent : 000185; suivant : 000187A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.
Auteurs : John S. Oxford [Royaume-Uni] ; Douglas Gill [Royaume-Uni]Source :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2019.
Descripteurs français
- KwdFr :
- Co-infection (), Co-infection (microbiologie), Co-infection (mortalité), Europe (épidémiologie), Grippe humaine (), Grippe humaine (histoire), Grippe humaine (épidémiologie), Histoire du 20ème siècle, Humains, Infections bactériennes (), Infections bactériennes (mortalité), Infections bactériennes (épidémiologie), Pandémies (histoire), Personnel de santé, Personnel militaire, Surinfection (), Surinfection (microbiologie), Surinfection (épidémiologie), Virologie, États-Unis d'Amérique (épidémiologie).
- MESH :
- histoire : Grippe humaine, Pandémies.
- microbiologie : Co-infection, Surinfection.
- mortalité : Co-infection, Infections bactériennes.
- épidémiologie : Europe, Grippe humaine, Infections bactériennes, Surinfection, États-Unis d'Amérique.
- Co-infection, Grippe humaine, Histoire du 20ème siècle, Humains, Infections bactériennes, Personnel de santé, Personnel militaire, Surinfection, Virologie.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Bacterial Infections (epidemiology), Bacterial Infections (mortality), Bacterial Infections (prevention & control), Coinfection (microbiology), Coinfection (mortality), Coinfection (prevention & control), Europe (epidemiology), Health Personnel, History, 20th Century, Humans, Influenza, Human (epidemiology), Influenza, Human (history), Influenza, Human (prevention & control), Military Personnel, Pandemics (history), Superinfection (epidemiology), Superinfection (microbiology), Superinfection (prevention & control), United States (epidemiology), Virology.
- MESH :
- geographic , epidemiology : Europe, United States.
- epidemiology : Bacterial Infections, Influenza, Human, Superinfection.
- history : Influenza, Human, Pandemics.
- microbiology : Coinfection, Superinfection.
- mortality : Bacterial Infections, Coinfection.
- prevention & control : Bacterial Infections, Coinfection, Influenza, Human, Superinfection.
- Health Personnel, History, 20th Century, Humans, Military Personnel, Virology.
Abstract
When we reconsider the virology and history of the Spanish Influenza Pandemic, the science of 2018 provides us with tools which did not exist at the time. Two such tools come to mind. The first lies in the field of 'gain of function' experiments. A potential pandemic virus, such as influenza A (H5N1), can be deliberately mutated in the laboratory in order to change its virulence and spreadability. Key mutations can then be identified. A second tool lies in phylogenetics, combined with molecular clock analysis. It shows that the 1918 pandemic virus first emerged in the years 1915-1916. We have revisited the literature published in Europe and the United States, and the notes left by physicians who lived at the time. In this, we have followed the words of the late Alfred Crosby: who wrote that "contemporary documentary evidence from qualified physicians" is the key to understanding where and how the first outbreaks occurred. In our view, the scientists working in Europe fulfill Crosby's requirement for contemporary evidence of origin. Elsewhere, Crosby also suggested that "the physicians of 1918 were participants in the greatest failure of medical science in the twentieth century". Ours is a different approach. We point to individual pathologists in the United States and in France, who strove to construct the first universal vaccines against influenza. Their efforts were not misdirected, because the ultimate cause of death in nearly all cases flowed from superinfections with respiratory bacteria.
DOI: 10.1080/21645515.2019.1607711
PubMed: 31121112
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:31121112Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.</title><author><name sortKey="Oxford, John S" sort="Oxford, John S" uniqKey="Oxford J" first="John S" last="Oxford">John S. Oxford</name><affiliation wicri:level="3"><nlm:affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</nlm:affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Blizard Institute, Queen Mary University London , Whitechapel </wicri:orgArea></affiliation></author><author><name sortKey="Gill, Douglas" sort="Gill, Douglas" uniqKey="Gill D" first="Douglas" last="Gill">Douglas Gill</name><affiliation wicri:level="3"><nlm:affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</nlm:affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Blizard Institute, Queen Mary University London , Whitechapel </wicri:orgArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31121112</idno><idno type="pmid">31121112</idno><idno type="doi">10.1080/21645515.2019.1607711</idno><idno type="wicri:Area/PubMed/Corpus">000134</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000134</idno><idno type="wicri:Area/PubMed/Curation">000134</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000134</idno><idno type="wicri:Area/PubMed/Checkpoint">000186</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000186</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.</title><author><name sortKey="Oxford, John S" sort="Oxford, John S" uniqKey="Oxford J" first="John S" last="Oxford">John S. Oxford</name><affiliation wicri:level="3"><nlm:affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</nlm:affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Blizard Institute, Queen Mary University London , Whitechapel </wicri:orgArea></affiliation></author><author><name sortKey="Gill, Douglas" sort="Gill, Douglas" uniqKey="Gill D" first="Douglas" last="Gill">Douglas Gill</name><affiliation wicri:level="3"><nlm:affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</nlm:affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Blizard Institute, Queen Mary University London , Whitechapel </wicri:orgArea></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bacterial Infections (epidemiology)</term><term>Bacterial Infections (mortality)</term><term>Bacterial Infections (prevention & control)</term><term>Coinfection (microbiology)</term><term>Coinfection (mortality)</term><term>Coinfection (prevention & control)</term><term>Europe (epidemiology)</term><term>Health Personnel</term><term>History, 20th Century</term><term>Humans</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (history)</term><term>Influenza, Human (prevention & control)</term><term>Military Personnel</term><term>Pandemics (history)</term><term>Superinfection (epidemiology)</term><term>Superinfection (microbiology)</term><term>Superinfection (prevention & control)</term><term>United States (epidemiology)</term><term>Virology</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Co-infection ()</term><term>Co-infection (microbiologie)</term><term>Co-infection (mortalité)</term><term>Europe (épidémiologie)</term><term>Grippe humaine ()</term><term>Grippe humaine (histoire)</term><term>Grippe humaine (épidémiologie)</term><term>Histoire du 20ème siècle</term><term>Humains</term><term>Infections bactériennes ()</term><term>Infections bactériennes (mortalité)</term><term>Infections bactériennes (épidémiologie)</term><term>Pandémies (histoire)</term><term>Personnel de santé</term><term>Personnel militaire</term><term>Surinfection ()</term><term>Surinfection (microbiologie)</term><term>Surinfection (épidémiologie)</term><term>Virologie</term><term>États-Unis d'Amérique (épidémiologie)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Europe</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bacterial Infections</term><term>Influenza, Human</term><term>Superinfection</term></keywords><keywords scheme="MESH" qualifier="histoire" xml:lang="fr"><term>Grippe humaine</term><term>Pandémies</term></keywords><keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Co-infection</term><term>Surinfection</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Coinfection</term><term>Superinfection</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Bacterial Infections</term><term>Coinfection</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Co-infection</term><term>Infections bactériennes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bacterial Infections</term><term>Coinfection</term><term>Influenza, Human</term><term>Superinfection</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term><term>Grippe humaine</term><term>Infections bactériennes</term><term>Surinfection</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Personnel</term><term>History, 20th Century</term><term>Humans</term><term>Military Personnel</term><term>Virology</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Co-infection</term><term>Grippe humaine</term><term>Histoire du 20ème siècle</term><term>Humains</term><term>Infections bactériennes</term><term>Personnel de santé</term><term>Personnel militaire</term><term>Surinfection</term><term>Virologie</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">When we reconsider the virology and history of the Spanish Influenza Pandemic, the science of 2018 provides us with tools which did not exist at the time. Two such tools come to mind. The first lies in the field of 'gain of function' experiments. A potential pandemic virus, such as influenza A (H5N1), can be deliberately mutated in the laboratory in order to change its virulence and spreadability. Key mutations can then be identified. A second tool lies in phylogenetics, combined with molecular clock analysis. It shows that the 1918 pandemic virus first emerged in the years 1915-1916. We have revisited the literature published in Europe and the United States, and the notes left by physicians who lived at the time. In this, we have followed the words of the late Alfred Crosby: who wrote that "contemporary documentary evidence from qualified physicians" is the key to understanding where and how the first outbreaks occurred. In our view, the scientists working in Europe fulfill Crosby's requirement for contemporary evidence of origin. Elsewhere, Crosby also suggested that "the physicians of 1918 were participants in the greatest failure of medical science in the twentieth century". Ours is a different approach. We point to individual pathologists in the United States and in France, who strove to construct the first universal vaccines against influenza. Their efforts were not misdirected, because the ultimate cause of death in nearly all cases flowed from superinfections with respiratory bacteria.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31121112</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.</ArticleTitle><Pagination><MedlinePgn>2009-2012</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1607711</ELocationID><Abstract><AbstractText>When we reconsider the virology and history of the Spanish Influenza Pandemic, the science of 2018 provides us with tools which did not exist at the time. Two such tools come to mind. The first lies in the field of 'gain of function' experiments. A potential pandemic virus, such as influenza A (H5N1), can be deliberately mutated in the laboratory in order to change its virulence and spreadability. Key mutations can then be identified. A second tool lies in phylogenetics, combined with molecular clock analysis. It shows that the 1918 pandemic virus first emerged in the years 1915-1916. We have revisited the literature published in Europe and the United States, and the notes left by physicians who lived at the time. In this, we have followed the words of the late Alfred Crosby: who wrote that "contemporary documentary evidence from qualified physicians" is the key to understanding where and how the first outbreaks occurred. In our view, the scientists working in Europe fulfill Crosby's requirement for contemporary evidence of origin. Elsewhere, Crosby also suggested that "the physicians of 1918 were participants in the greatest failure of medical science in the twentieth century". Ours is a different approach. We point to individual pathologists in the United States and in France, who strove to construct the first universal vaccines against influenza. Their efforts were not misdirected, because the ultimate cause of death in nearly all cases flowed from superinfections with respiratory bacteria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oxford</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary University London , Whitechapel , London.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015163" MajorTopicYN="N">Superinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Etaples Administrative District</Keyword><Keyword MajorTopicYN="Y">Hospital Beds in the Great War</Keyword><Keyword MajorTopicYN="Y">Hygiene in the Great War</Keyword><Keyword MajorTopicYN="Y">Influenza Epidemics in 1917</Keyword><Keyword MajorTopicYN="Y">New Vaccines</Keyword><Keyword MajorTopicYN="Y">Spanish Influenza Origin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31121112</ArticleId><ArticleId IdType="doi">10.1080/21645515.2019.1607711</ArticleId><ArticleId IdType="pmc">PMC6773402</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2018 Feb 8;36(7):932-938</Citation><ArticleIdList><ArticleId IdType="pubmed">29221895</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11059-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16046546</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8107-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24778238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2018 Nov;18(11):e348-e354</Citation><ArticleIdList><ArticleId IdType="pubmed">29935779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 May 02;486(7403):420-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22722205</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Jun 22;336(6088):1534-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22723413</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2004 Jul;103(1-2):173-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15163506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Sep;21(9):1065-70</Citation><ArticleIdList><ArticleId IdType="pubmed">26301691</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Sep 18;349(6254):1301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26303961</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2015;386:301-21</Citation><ArticleIdList><ArticleId IdType="pubmed">25007847</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Oct 1;198(7):962-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Oxford, John S" sort="Oxford, John S" uniqKey="Oxford J" first="John S" last="Oxford">John S. Oxford</name></region><name sortKey="Gill, Douglas" sort="Gill, Douglas" uniqKey="Gill D" first="Douglas" last="Gill">Douglas Gill</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000186 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000186 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:31121112
|texte= A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:31121112" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |